Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Terconazole. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 19/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 1.00 |
| ▸ | CYP51A1 | Q16850 | 3/20 | 1.00 |
| ▸ | FYN | P06241 | 2/20 | 1.00 |
| ▸ | NR1I2 | O75469 | 2/20 | 1.00 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 1.00 |
| ▸ | CHRM2 | P08172 | 2/20 | 1.00 |
| ▸ | ADRA2A | P08913 | 2/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 1.00 |
| ▸ | ADRA2B | P18089 | 2/20 | 1.00 |
| ▸ | SLC6A2 | P23975 | 2/20 | 1.00 |
| ▸ | HTR2A | P28223 | 2/20 | 1.00 |
| ▸ | SLC6A4 | P31645 | 2/20 | 1.00 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 2/20 | 1.00 |
| ▸ | PGR | P06401 | 1/20 | 1.00 |
| ▸ | CHRM4 | P08173 | 1/20 | 1.00 |
| ▸ | CHRM5 | P08912 | 1/20 | 1.00 |
| ▸ | CHRM1 | P11229 | 1/20 | 1.00 |
| ▸ | ADRA2C | P18825 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Terconazole SCHEMBL4924542 | 1.00 | CYP3A4 (1.00) | CYP3A4LMNACYP51A1FYNNR1I2 | |
| Terconazole SCHEMBL17493426 | 1.00 | CYP3A4 (1.00) | CYP3A4LMNACYP51A1FYNNR1I2 | |
| Terconazole SCHEMBL7601910 | 1.00 | CYP3A4 (1.00) | CYP3A4LMNACYP51A1FYNNR1I2 | |
| Terconazole SCHEMBL18258318 | 1.00 | CYP3A4 (1.00) | CYP3A4LMNACYP51A1FYNNR1I2 | |
| Terconazole SCHEMBL5008913 | 1.00 | CYP3A4 (1.00) | CYP3A4LMNACYP51A1FYNNR1I2 | |
| Terconazole SCHEMBL29388408 | 1.00 | CYP3A4 (1.00) | CYP3A4LMNACYP51A1FYNNR1I2 | |
| Terconazole SCHEMBL4923831 | 0.99 | CYP3A4 (0.98) | CYP3A4LMNACYP51A1FYNNR1I2 | |
| Terconazole SCHEMBL9043676 | 0.99 | CYP3A4 (0.98) | CYP3A4LMNACYP51A1FYNNR1I2 | |
| Terconazole SCHEMBL1066299 | 0.94 | CYP3A4 (0.89) | CYP3A4LMNACYP51A1FYNNR1I2 | |
| Terconazole SCHEMBL6233263 | 0.94 | CYP3A4 (0.89) | CYP3A4LMNACYP51A1FYNNR1I2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 23751 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026106952-A1 | METHODS FOR TREATING CONGENITAL DISORDERS OF GLYCOSYLATION | CDG CARE (US) | 2026-05-21 | — | — | WO | claimed |
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| US-20260102419-A1 | USE OF COMPOUNDS IN THE TREATMENT OF FUNGAL INFECTIONS | BASILEA PHARMACEUTICA INTERNATIONAL AG, ALLSCHWIL (CH) | 2026-04-16 | — | — | US | claimed |
| EP-4719384-A2 | COMPOUNDS WITH ANTIFUNGAL PROPERTIES | Trustees of Dartmouth College (US) | 2026-04-08 | — | — | EP | claimed |
| US-20260027140-A1 | COMPOSITIONS AND METHODS FOR TREATING AND AMELIORATING RESPIRATORY CONDITIONS AND INFLAMMATION OF MUCOSA | ATOPIC MEDICAL INC (US) | 2026-01-29 | — | — | US | claimed |
| EP-4680240-A1 | METHOD OF TREATING DISORDERS WITH SURF1 MALFUNCTION | Cure Mito Foundation (US) | 2026-01-21 | — | — | EP | claimed |
| EP-4676500-A2 | MICROBIAL CONSORTIA | Kanvas Biosciences, Inc (US) | 2026-01-14 | — | — | EP | claimed |
| US-20260007753-A1 | DERMAL SKIN PROTECTANT AND CARRIER | INSPIRED MAT STRATEGIES LLC (US) | 2026-01-08 | — | — | US | claimed |
| US-12419959-B2 | Dermal skin protectant and carrier | Inspired Material Strategies, LLC (US) | 2025-09-23 | — | — | US | claimed |
| US-20250281464-A1 | TREATMENT OF PATHOGENIC NEISSERIA SP. INFECTION WITH TRIAZOLE ANTIFUNGAL AGENTS | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. | 2025-09-11 | — | — | US | claimed |
| EP-0221950-A1 | ELASTOMERIC CONTROLLED RELEASE FORMULATION AND ARTICLE COMPRISING SAME. | AMERICAN TELEPHONE & TELEGRAPH (US) | 1987-05-20 | — | — | EP | claimed |
| WO-1987002219-A1 | ALPHA TOCOPHEROL-BASED VESICLES | THE LIPOSOME COMPANY, INC. (US) | 1987-04-23 | — | — | WO | claimed |
| US-4659576-A | Shelf or refrigerator stable raw alimentary paste | CAMPBELL SOUP COMPANY (US) | 1987-04-21 | — | — | US | claimed |
| WO-1986006252-A1 | ELASTOMERIC CONTROLLED RELEASE FORMULATION AND ARTICLE COMPRISING SAME | AMERICAN TELEPHONE & TELEGRAPH COMPANY (US) | 1986-11-06 | — | — | WO | claimed |
| WO-1986005977-A1 | STEROIDAL LIPOSOMES | THE LIPOSOME COMPANY, INC. (US) | 1986-10-23 | — | — | WO | claimed |
| US-4607594-A | Animal litter | RAETEC INDUSTRIES, INC. (US) | 1986-08-26 | — | — | US | claimed |
| US-4605553-A | Dry pressed powder stick composition and vehicle therefor | PASSALACQUA PETER | 1986-08-12 | — | — | US | claimed |
| US-4594380-A | Active material in polyurethane matrix | AT&T BELL LABORATORIES (US) | 1986-06-10 | — | — | US | claimed |
| US-4102810-A | ETHOXYLATED PHENOL, ALKALI METAL FLUORIDE | COULTER ELECTRONICS, INC. (US) | 1978-07-25 | — | — | US | claimed |
| US-4052190-A | SUSTAINED-RELEASE PLANT FOOD | BURNISHINE PRODUCTS INC. (US) | 1977-10-04 | — | — | US | claimed |